Intravenous injection of cyclosporin A loaded lipid nanocapsules fights inflammation and immune system activation in a mouse model of diabetic retinopathy

URN to cite this document:: urn:nbn:de:bvb:355-epub-542611
DOI to cite this document:: 10.5283/epub.54261

Bohley, Marilena

; Dillinger, Andrea E. ; Braunger, Barbara M. ; Tamm, Ernst R. ; Goepferich, Achim

License: Creative Commons Attribution 4.0
PDF - Published Version
(6MB)

Date of publication of this fulltext: 23 May 2023 06:22

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Inflammation and immune system activation are key pathologic events in the onset and escalation of diabetic retinopathy (DR). Both are driven by cytokines and complement originating from the retinal pigment epithelium (RPE). Despite the RPE’s pivotal role, there is no therapeutic tool to specifically interfere with the RPE-related pathomechanism. A therapy that addresses RPE cells and counteracts ...